BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25955226)

  • 1. The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism.
    Harsløf T; Sikjær T; Sørensen L; Pedersen SB; Mosekilde L; Langdahl BL; Rejnmark L
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2758-62. PubMed ID: 25955226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).
    Schafer AL; Sellmeyer DE; Schwartz AV; Rosen CJ; Vittinghoff E; Palermo L; Bilezikian JP; Shoback DM; Black DM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1982-9. PubMed ID: 21994958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk Between Bone and Fat Tissue: Associations Between Vitamin D, Osteocalcin, Adipokines, and Markers of Glucose Metabolism Among Adolescents.
    Giudici KV; Fisberg RM; Marchioni DML; Peters BSE; Martini LA
    J Am Coll Nutr; 2017; 36(4):273-280. PubMed ID: 28443718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
    Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L;
    J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surgically induced weight loss by Roux-en-Y gastric bypass on osteocalcin.
    Maser RE; James Lenhard M; Balagopal PB; Kolm P; Peters MB
    Surg Obes Relat Dis; 2013; 9(6):950-5. PubMed ID: 23211649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
    Szulc P; Chapuy MC; Meunier PJ; Delmas PD
    J Clin Invest; 1993 Apr; 91(4):1769-74. PubMed ID: 8473517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women.
    Lu C; Ivaska KK; Alen M; Wang Q; Törmäkangas T; Xu L; Wiklund P; Mikkola TM; Pekkala S; Tian H; Väänänen HK; Cheng S
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4106-14. PubMed ID: 22948754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism.
    Maser RE; Lenhard MJ; Pohlig RT; Balagopal PB; Abdel-Misih R
    Endocr Res; 2018 Feb; 43(1):21-28. PubMed ID: 28937873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism.
    Harslof T; Sikjaer T; Mosekilde L; Langdahl BL; Rejnmark L
    Int J Endocrinol Metab; 2016 Jul; 14(3):e38440. PubMed ID: 27942265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance.
    Chen X; Wu Y; Liu L; Tian H; Yu X
    Diabetes Metab Res Rev; 2014 Sep; 30(6):476-82. PubMed ID: 24339141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone therapy for hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
    Liu XX; Zhu XY; Mei GH
    Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
    Rejnmark L; Gosmanova EO; Khan AA; Makita N; Imanishi Y; Takeuchi Y; Sprague S; Shoback DM; Kohlmeier L; Rubin MR; Palermo A; Schwarz P; Gagnon C; Tsourdi E; Zhao C; Makara MA; Ominsky MS; Lai B; Ukena J; Sibley CT; Shu AD
    Adv Ther; 2024 Jun; 41(6):2500-2518. PubMed ID: 38691316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undercarboxylated osteocalcin, muscle strength and indices of bone health in older women.
    Levinger I; Scott D; Nicholson GC; Stuart AL; Duque G; McCorquodale T; Herrmann M; Ebeling PR; Sanders KM
    Bone; 2014 Jul; 64():8-12. PubMed ID: 24662619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women.
    Lewis JR; Brennan-Speranza TC; Levinger I; Byrnes E; Lim EM; Blekkenhorst LC; Sim M; Hodgson JM; Zhu K; Lim WH; Adams LA; Prince RL
    Osteoporos Int; 2019 Oct; 30(10):2065-2072. PubMed ID: 31342138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial.
    Rasekhi H; Karandish M; Jalali MT; Mohammad-Shahi M; Zarei M; Saki A; Shahbazian H
    Eur J Clin Nutr; 2015 Aug; 69(8):891-5. PubMed ID: 25782427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Intriguing Correlation between Undercarboxylated Osteocalcin and Vitamin D.
    Buranasinsup S; Bunyaratavej N
    J Med Assoc Thai; 2015 Sep; 98 Suppl 8():S16-20. PubMed ID: 26529809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.